News
From artificial intelligence to augmented reality, technology is transforming the Property & Casualty insurance and collision repair ecosystem. Whether your area of focus is collision claims, collision repair, first or third party casualty, workersâ compensation or pharmacy, Mitchell is your source for information and expert opinions on the latest technology and business trends.
Mitchell Teams With Mazda North American Operations to Launch U.S. Collision Repair Network
May 4, 2021
New program reaffirms Mazda's mission to brighten lives through car ownership by supporting the proper, safe repair of collision-damaged vehicles.
Mitchellâs Q1 Industry Trends Report Examines the Ongoing Effects of COVID-19 and Implications for Property & Casualty Claims and Collision Repair
March 9, 2021
One full year after the first stay-at-home orders were issued, Mitchell experts share views, changes and trends from 2020 to better understand what may be around the corner.
Mitchell Introduces New Alternative for AI-Enabled Claims Processing Through Collaboration with Claim Genius
March 3, 2021
Company's ongoing expansion of the Mitchell Intelligent Open Platform (MIOP) delivers more AI flexibility to generate damage appraisals.
Bosch and Mitchell Introduce New Target System for Static ADAS Calibration
February 3, 2021
Using the Mitchell Diagnostics MD-TS21, collision repairers can increase workflow efficiency, reduce cycle time and generate additional revenue by performing calibrations in-house.
Mitchell Expands Claims Automation Capabilities Through Open Platform and Collaboration With Tractable
January 27, 2021
Company's flexible, end-to-end solution now supports Tractable's artificial intelligence (AI).
Navigating the CARES Act Emergency Small Business Funding
January 15, 2021
Learn about the Coronavirus Aid, Relief and Economic Security (CARES) Act and how you can apply for PPP and EIDL Small Business Administration (SBA) loans.
FDA Authorizes Second Coronavirus (SARS-CoV2) Vaccine for Use
December 23, 2020
The vaccine produced by Moderna has been granted emergency use authorization for distribution in the United States.